Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
630.1000 -3.70 (-0.58%)
NSE Jan 13, 2026 15:31 PM
Volume: 536.4K
 

630.10
-0.58%
ICICI Securities Limited
Integrated business model, customer stickiness to the fore Revenues grew at ~21% CAGR in FY15-19 to | 1826 crore due to new client addition on a regular basis and scaled up revenues from existing clients led by integrated service offerings, high data integrity ethos and continuous endeavour to move up the value chain. Eight of the top 10 global pharma companies have been availing services for the last five years. It owns a pool...
Number of FII/FPI investors increased from 279 to 293 in Sep 2025 qtr.
More from Syngene International Ltd.
Recommended